Natco Pharma Ltd. announced that Dr. Jasti Sambasiva Rao, Director of the company resigned as a Director due to his personal preoccupations.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,105 INR | +0.64% | +13.90% | +36.22% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.22% | 2.35B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Jasti Sambasiva Rao Resigns as Director of Natco Pharma Limited